Compression Gloves for Distal Radius Fracture
Launched by CLALIT HEALTH SERVICES · Jan 21, 2012
Trial Information
Current as of August 19, 2025
Completed
Keywords
ClinConnect Summary
Individuals referred for rehabilitation following DRF will be invited to participate in the study. After obtaining an informed consent individuals will be randomized to receive routine follow up and treatment with or without compression glove. Individuals randomized to made to measure compression gloves will receive them within a week of enrolment. All participating individuals will be assessed by an occupational therapist at enrolment and 2, 4, and 8 week after enrolment. Additional telephone interview, to assess long term effect, will be conducted at 3, 6 and 12 months.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. 4-6 weeks following either surgical or conservative treatment for distal Radius fractures, with or without the involvement of the Ulna.
- 2. Patients who demonstrate at enrolment at least two of the following:
- • Pain,
- • limited range of motion of the fingers and the wrist,
- • limited strength (weakness of the hand/fingers),
- • swelling /edema,
- • Limited hand functions during performance of Activities of Daily Living (ADL).
- Exclusion Criteria:
- • Neuropathy
- • Peripheral vascular disease
- • End stage renal disease
- • Previous impairment of fingers/wrist range of motion.
- • Previous Lymphedema of the injured hand
- • Receiving any additional treatments which is not included in the routine follow up and treatment (i.e. acupuncture, steroids).
- • Pregnancy
About Clalit Health Services
Clalit Health Services is a leading healthcare organization in Israel, renowned for its comprehensive approach to patient care and health management. As the largest health maintenance organization (HMO) in the country, Clalit integrates medical services, research, and education, offering a wide range of clinical trials aimed at advancing medical knowledge and improving patient outcomes. With a strong emphasis on innovation and evidence-based practices, Clalit collaborates with academic institutions and industry partners to facilitate cutting-edge research across various therapeutic areas, ensuring the highest standards of ethical conduct and patient safety.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Haifa, , Israel
Haifa, , Israel
Patients applied
Trial Officials
Benny Brnfeld, MD
Principal Investigator
Clalit Health Services
Uzi Milman, MD
Study Director
Clalit Health Services
Naomi Schreuer, Ph.D., OTR
Study Chair
Faculty of Social Welfare & Health Sciences, University of Haifa, Haifa, ISRAEL
Inbar Miler, OCT
Principal Investigator
Clalit Health Services
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials